Epstein Secrets

interference," but rather "found that the British government did not really seem to take the issue seriously." The New Ynrk Times (7/21, Landler, Castle, 18.61M) says the report, which is "in many ways harder on British officials than the Russians, did not answer the question of whether Russia swayed

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline

e issue seriously." The New York Times <https://www.nytimes.corn/2020/07/21/world/europe/uk-russia-report-brexit- interference.html> (7/21, Landler, Castle, 18.61M) says the report, which is "in many ways harder on British officials than the Russians, did not answer the question of whether Russia swayed

2021/5478232002/> (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Modema and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guidelines.

kdown Next Week. The New York Times <https://www.nytimes.com/2020/11/23/world/europe/UK-johnson-lockdown-vaccine- astrazeneca.html> (11/23, Landler, Castle, 18.61M) reports, "Buoyed by promising results for a British-led coronavirus vaccine and signs of a slowdown in the infection rate, Prime Minister B

ting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg

much, they risk a third surge of COVID-19 infections. UK's Johnson Lays Out Plans To Lift Lockdown Next Week. The New York Times (11/23, Landler, Castle, 18.61M) reports, "Buoyed by promising results for a British-led coronavirus vaccine and signs of a slowdown in the infection rate, Prime Minister

ing an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behind." Some Countries Face "Immense" Stakes With AstraZeneca's Vaccine. Bloomberg (1

n interference," but rather "found that the British government did not really seem to take the issue seriously." The New York Times (7/21, Landler, Castle, 18.61M) says the report, which is "in many ways harder on British officials than the Russians, did not answer the question of whether Russia swaye

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline

" but rather "found that the British government did not really seem to take the issue seriously." EFTA01658215 The New York Times (7/21, Landler, Castle, 18.61M) says the report, which is "in many ways harder on British officials than the Russians, did not answer the question of whether Russia swaye

afety. USA Today (7/21, Weise, 10.31M) reports in testimony to a US House subcommittee on Tuesday, "executives from AstraZeneca, Johnson & Johnson, Merck, Moderna and Pfizer said their goal is to have effective vaccines available as soon as possible while following all safety and regulatory guideline